Skip to content
-
NASP’s Letter to Superintendent Adrienne A. Harris regarding NY State Regulations
Oct 19, 2023
View the pdf here. RE: Regulations on Market Conduct Rules for Pharmacy Benefit Managers Dear Superintendent... read more
-
Listen to The NASP 2023 Recap Podcast, Part 1!
Oct 12, 2023
The first part of the NASP 2023 Annual Meeting & Expo ReCap show is live! Listen &... read more
-
EVERSANA Expands Global Commercialisation Capabilities and Strengthens Agency Network with Healthware Group Acquisition
Oct 11, 2023
Healthware will immediately merge with EVERSANA INTOUCH, shifting from long-standing partnership to a full-service global, award-winning... read more
-
Spotlight Corporate Member of the Month, Capital Drug, September 2023
Sep 25, 2023
NASP is pleased to shine the SPOTLIGHT on Capital Drug, a September corporate member of the month. Capital... read more
-
EVERSANA Unveils ACTICS® eAccess, New Technology-Enabled eBV and ePA Patient Support Platform to Improve Patient Access and Accelerate Speed to Therapy
Sep 18, 2023
CHICAGO – September 18, 2023 – EVERSANA®, a leading provider of commercialization services to the global... read more
-
Spotlight Corporate Member of the Month, eMazzanti Technologies, September 2023
Sep 11, 2023
NASP is pleased to shine the SPOTLIGHT on eMazzanti Technologies, a September corporate member of the month. eMazzanti is... read more
-
Spotlight Corporate Member of the Month, Claritas Rx, September 2023
Sep 05, 2023
NASP is pleased to shine the SPOTLIGHT on Claritas Rx, a September corporate member of the month. Claritas Rx... read more
-
Listen to The Elephant in the Room – The Looming Healthcare Crisis with Inovalon
Aug 24, 2023
The newest NASP Podcast is now live! Click here to listen to “The Elephant in the Room... read more
-
Spotlight Corporate Member of the Month, August 2023
Aug 07, 2023
NASP is pleased to shine a bright light this week on Pharmacyclics, LLC, the corporate member... read more
-
NASP Thanks the Senate Finance Committee for Taking Initial Steps to Address Anticompetitive PBM Practices
Jul 28, 2023
Urges the Committee to Do More to Support Specialty Pharmacies and Patient Pharmacy Choice NASP is... read more